famotidine

Generic: famotidine

Labeler: athenex pharmaceutical division, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler athenex pharmaceutical division, llc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

famotidine 10 mg/mL

Manufacturer
Athenex Pharmaceutical Division, LLC.

Identifiers & Regulatory

Product NDC 70860-751
Product ID 70860-751_2cc9707d-b7b9-36ec-e063-6294a90a1e44
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075622
Marketing Start 2020-08-10
Marketing End 2026-07-31

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70860751
Hyphenated Format 70860-751

Supplemental Identifiers

RxCUI
204441 1743833
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA075622 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 CARTON (70860-751-02) / 2 mL in 1 VIAL, SINGLE-DOSE (70860-751-41)
source: ndc

Packages (1)

70860-751-02 25 VIAL, SINGLE-DOSE in 1 CARTON (70860-751-02) / 2 mL in 1 VIAL, SINGLE-DOSE (70860-751-41)

Ingredients (1)

famotidine (10 mg/mL)

Linked Drug Pages (1)

Famotidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2cc9707d-b7b9-36ec-e063-6294a90a1e44", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["204441", "1743833"], "spl_set_id": ["234d941f-5754-4d83-b02e-26638e0054e6"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Athenex Pharmaceutical Division, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (70860-751-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (70860-751-41)", "package_ndc": "70860-751-02", "marketing_end_date": "20260731", "marketing_start_date": "20200810"}], "brand_name": "Famotidine", "product_id": "70860-751_2cc9707d-b7b9-36ec-e063-6294a90a1e44", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "70860-751", "generic_name": "famotidine", "labeler_name": "Athenex Pharmaceutical Division, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "10 mg/mL"}], "application_number": "ANDA075622", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "20200810"}